Medicine | Oncology
CNS tumors | Embryonal tumors

Medulloblastoma
Etiology, Pathogenesis, Pathology


Home > Disciplines > Medicine > Oncology > CNS Tumors > Embryonal tumors > Medulloblastoma > Etiology, Pathogenesis, and Pathology


Overview




EPIGENETICS


.

Roussel MF, Stripay JL.
Epigenetic Drivers in Pediatric Medulloblastoma.
Cerebellum. 2017 Nov 25. doi: 10.1007/s12311-017-0899-9. [Epub ahead of print]
Source | Full text | Similar articles



.

Yi J, Wu J.
Epigenetic regulation in medulloblastoma.
Mol Cell Neurosci. 2018 Mar;87:65-76. doi: 10.1016/j.mcn.2017.09.003. Epub 2017 Dec 18.
Source | Full text | Similar articles



METASTASIS


.

Ferrucci V, de Antonellis P, Pennino FP, Asadzadeh F, Virgilio A, Montanaro D, Galeone A, Boffa I, Pisano I, Scognamiglio I, Navas L, Diana D, Pedone E, Gargiulo S, Gramanzini M, Brunetti A, Danielson L, Carotenuto M, Liguori L, Verrico A, Quaglietta L, Errico ME, Del Monaco V, D'Argenio V, Tirone F, Mastronuzzi A, Donofrio V, Giangaspero F, Picard D, Remke M, Garzia L, Daniels C, Delattre O, Swartling FJ, Weiss WA, Salvatore F, Fattorusso R, Chesler L, Taylor MD, Cinalli G, Zollo M.
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Brain. 2018 Feb 27. doi: 10.1093/brain/awy039. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



EXTRANEURAXIAL METASTASES



Gupta T, Dasgupta A, Epari S, Shirsat N, Chinnaswamy G, Jalali R.
Extraneuraxial metastases in medulloblastoma: is histology and molecular biology important?
J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2586-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



LEPTOMENINGEAL METASTASES


.

Fults DW, Taylor MD, Garzia L.
Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.
J Neurosurg Pediatr. 2019 Feb 15:1-9. doi: 10.3171/2018.11.PEDS18506. [Epub ahead of print]
Source | Abstract | Similar articles



.

Garzia L, Kijima N, Morrissy AS, De Antonellis P, Guerreiro-Stucklin A, Holgado BL, Wu X, Wang X, Parsons M, Zayne K, Manno A, Kuzan-Fischer C, Nor C, Donovan LK, Liu J, Qin L, Garancher A, Liu KW, Mansouri S, Luu B, Thompson YY, Ramaswamy V, Peacock J, Farooq H, Skowron P, Shih DJH, Li A, Ensan S, Robbins CS, Cybulsky M, Mitra S, Ma Y, Moore R, Mungall A, Cho YJ, Weiss WA, Chan JA, Hawkins CE, Massimino M, Jabado N, Zapotocky M, Sumerauer D, Bouffet E, Dirks P, Tabori U, Sorensen PHB, Brastianos PK, Aldape K, Jones SJM, Marra MA, Woodgett JR, Wechsler-Reya RJ, Fults DW, Taylor MD.
A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.
Cell. 2018 Feb 22;172(5):1050-1062.e14. doi: 10.1016/j.cell.2018.01.038. Corrected online March 7, 2018.
Source | Abstract | Full text | Similar articles



.

[No authors listed]
Medulloblastoma Circulating Tumor Cells Form Leptomeningeal Metastases.
Cancer Discov. 2018 Apr;8(4):383. doi: 10.1158/2159-8290.CD-RW2018-035. Epub 2018 Mar 2.
Comment on: Garzia L et al., A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases. Cell. 2018 Feb 22
Source | Abstract | Full text | Similar articles



PROGRESSION



Liu Y, Yuelling LW, Wang Y, Du F, Gordon RE, O'Brien J, Ng JMY, Robins S, Lee EH, Liu H, Curran T, Yang ZJ.
Astrocytes promote medulloblastoma progression through hedgehog secretion.
Cancer Res. 2017 Oct 6. pii: canres.1463.2017. doi: 10.1158/0008-5472.CAN-17-1463. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



SUBGROUPS



Benmaamar R.
Redefining the molecular substructure of medulloblastoma.
Comment on: Northcott PA, The whole-genome landscape of medulloblastoma subtypes.
Lancet Oncol. 2017 Sep;18(9):e514. doi: 10.1016/S1470-2045(17)30571-5. Epub 2017 Jul 27.
Source | Abstract | Full text | Similar articles




Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.
Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.
Source | Abstract | Full text | Similar articles




Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jäger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jäger-Schmidt C, Imbusch CD, Jugold A, Hübschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P.
The whole-genome landscape of medulloblastoma subtypes.
Nature. 2017 Jul 19;547(7663):311-317. doi: 10.1038/nature22973.
Source | Abstract | Full text | Similar articles




Ramaswamy V, Taylor MD.
Medulloblastoma: From Myth to Molecular.
J Clin Oncol. 2017 Jun 22:JCO2017727842. doi: 10.1200/JCO.2017.72.7842. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, Rafiee G, Hill RM, Iliasova A, Stone T, Pizer B, Michalski A, Joshi A, Wharton SB, Jacques TS, Bailey S, Williamson D, Clifford SC.
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Lancet Oncol. 2017 May 22. pii: S1470-2045(17)30243-7. doi: 10.1016/S1470-2045(17)30243-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sengupta S, Pomeranz Krummel D, Pomeroy S.
The evolution of medulloblastoma therapy to personalized medicine.
F1000Res. 2017 Apr 13;6:490. doi: 10.12688/f1000research.10859.1. eCollection 2017.
Source | Abstract | Full text | Similar articles




Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM.
Molecular subgroups of medulloblastoma: the current consensus.
Acta Neuropathol. 2012 Apr;123(4):465-72. doi: 10.1007/s00401-011-0922-z. Epub 2011 Dec 02
Source | Abstract | Full text | Similar articles



.

Zapotocky M, Mata-Mbemba D, Sumerauer D, Liby P, Lassaletta A, Zamecnik J, Krskova L, Kyncl M, Stary J, Laughlin S, Arnoldo A, Hawkins C, Tabori U, Taylor MD, Bouffet E, Raybaud C, Ramaswamy V.
Differential patterns of metastatic dissemination across medulloblastoma subgroups.
J Neurosurg Pediatr. 2017 Dec 8:1-8. doi: 10.3171/2017.8.PEDS17264. [Epub ahead of print] Erratum DOI: https://doi.org/10.3171/2017.12.PEDS17264a
Source | Full text | Similar articles | Erratum



Non-wingless-activated (WNT)/non-sonic hedgehog-activated (SHH) category


.

Menyhárt O, Giangaspero F, Győrffy B.
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas.
J Hematol Oncol. 2019 Mar 15;12(1):29. doi: 10.1186/s13045-019-0712-y.
Source | Full text | Similar articles



Laboratory investigations




TUMOR CELL IMMORTALIZATION


.

Minasi S, Baldi C, Pietsch T, Donofrio V, Pollo B, Antonelli M, Massimino M, Giangaspero F, Buttarelli FR.
Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
J Neurooncol. 2019 Mar 4. doi: 10.1007/s11060-019-03127-w. [Epub ahead of print]
Source | Full text | Similar articles